Abbott (NYSE:ABT) today announced FDA approval of an expanded indication for the company’s Infinity deep brain stimulation system. Abbott boasts that Infinity is now the only directional DBS system approved for all major targets used to treat movement disorders, Parkinson’s disease and essential tremor. The new indication is for targetting the brain’s internal globus pallidus (GPi), […]
NANS 2020: Neuromodulation news you need to know
Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]
Medtronic touts 3-month clinical trial results using Stimgenics spinal cord stimulation
Medtronic (NYSE:MDT) this week touted results from a three-month clinical trial of the recently acquired Stimgenics Differential Target Multiplexed Spinal Cord Stimulation using Medtronic’s Intellis platform. The large, multicenter randomized controlled trial showed that 80% of patients with chronic back pain that were treated with Differential Target Multiplexed (DTM) reported at least 50% pain relief […]
Axonics wins FDA approval for enhanced neurostimulator programmer
Axonics Modulation Technologies (NSDQ:AXNX) announced today that it won FDA approval for a second-generation programmer for its r-SNM sacral neuromodulation system. The Irvine, Calif.–based company’s new programmer is designed to program the Axonics external trial neurostimulator and the implantable neurostimulator in the procedure and post-operative environments, according to a news release. The device is a touchscreen […]
Nevro names new VP of clinical, regulatory and quality
Nevro (NYSE:NVRO) this week said it appointed Donald Middlebrook as VP of clinical, regulatory and quality. Middlebrook will report directly to CEO and president Keith Grossman. “We’re pleased to have a leader of Don’s caliber join Nevro to advance our clinical pipeline and oversee our global regulatory and quality initiatives,” Grossman said in a news release. […]
StimGuard appoints new chief financial officer
StimGuard today said it appointed Stephen Deitsch as chief financial officer, effective Jan. 15. Deitsch has 20 years of corporate financial leadership experience in medtech and healthcare. He replaces interim chief financial officer Gil Bao, who will transition into the role of director of strategy. “We are excited that Steve will be joining StimGuard’s executive […]
Phagenesis wins FDA breakthrough nod for Phagenyx System for restoring swallowing
Phagenesis announced today that it won breakthrough device designation from the FDA for its Phagenyx System for restoring neurological swallowing control. The Phagenyx System is a neurostimulation device designed to use pharyngeal electrical stimulation to treat the cause of dysphagia, accelerating the removal of the breathing tube in the process. Severe dysphagia with related insufficient […]
Medtronic wins CE Mark for next-gen InterStim products
Medtronic (NYSE:MDT) announced today that it received CE Mark approval for its InterStim Micro neurostimulator and InterStim SureScan MRI leads. The medtech giant plans to make the products available on the market on Jan. 15 to expand access to sacral neuromodulation (SNM) therapy for European patients, according to a news release. InterStim Micro is a rechargeable […]
Miles White’s fearless strategy for growing Abbott
With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into one of the world’s largest medical device companies. Few medical device companies have seen the growth and transformation that Abbott (NYSE:ABT) has seen under the leadership of Miles White. During his two decades as […]
Medtronic wins CE Mark for Percept PC neurostimulator
Medtronic (NYSE:MDT) said today that it has secured a CE Mark for its Percept PC neurostimulator. The medical device giant is touting Percept PC as the only deep brain stimulation (DBS) system launched in the EU with BrainSense technology — which senses and records brain signals while delivering DBS therapy to people with neurological disorders such […]
Medtronic acquires Stimgenics
Medtronic (NYSE:MDT) yesterday said it acquired spinal cord stimulation company Stimgenics for an undisclosed amount. Stimgenics has developed a spinal cord stimulation waveform known as Differential Target Multiplexed Spinal Cord Stimulation. The therapy is delivered through Medtronic’s Intellis platform and is a chronic pain treatment option. “Stimgenics’s research is deeply rooted in clinical science that began […]
- 1
- 2
- 3
- …
- 84
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube